drugset
drugset / Trial / NCT00557700

Study to Investigate the Effect of Inhaled Tiotropium Bromide on Neurokinin-A Induced Bronchoconstriction in Patients With Mild-to-moderate Asthma

NCT00557700 ↗

Phase 2 Completed 15 enrolled University Hospital, Ghent Boehringer Ingelheim · collab
RandomizedCrossoverDouble-blindTreatment

Summary

This trial compares the outcome of treatment of mild to moderate asthma: inhaled tiotropium bromide versus placebo.

Timeline

Start
2008-01
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified — Inhaled

Indications

asthma